Catheter Precision, Inc. (NYSEAMERICAN:VTAK – Get Free Report) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totaling 93,100 shares, a growth of 77.0% from the September 30th total of 52,600 shares. Approximately 6.4% of the shares of the company are sold short. Based on an average daily volume of 1,130,000 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 1,130,000 shares, the short-interest ratio is currently 0.1 days. Approximately 6.4% of the shares of the company are sold short.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Catheter Precision stock. Armistice Capital LLC increased its position in Catheter Precision, Inc. (NYSEAMERICAN:VTAK – Free Report) by 94.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 250,965 shares of the company’s stock after buying an additional 121,800 shares during the period. Armistice Capital LLC owned about 2.84% of Catheter Precision worth $86,000 at the end of the most recent quarter. Institutional investors and hedge funds own 20.34% of the company’s stock.
Catheter Precision Trading Up 2.1%
Shares of Catheter Precision stock opened at $2.45 on Monday. The company has a quick ratio of 0.43, a current ratio of 0.44 and a debt-to-equity ratio of 0.19. The company has a fifty day moving average of $2.56 and a 200 day moving average of $3.94. Catheter Precision has a fifty-two week low of $2.20 and a fifty-two week high of $15.68.
About Catheter Precision
Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.
Featured Stories
- Five stocks we like better than Catheter Precision
- Trading Halts Explained
- Is Lemonade Stock Set for a Big Squeeze After Earnings?
- What is a buyback in stocks? A comprehensive guide for investors
- Caterpillar Stock Could Top $650 by Year’s End
- What is a Special Dividend?
- ServiceNow’s 5-for-1 Split Is a Signal for Investors to Buy
Receive News & Ratings for Catheter Precision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catheter Precision and related companies with MarketBeat.com's FREE daily email newsletter.
